Pfizer
Wikidi home Organization Category Pfizer
Summary |
||
| Date founded |
1849
|
|
|---|---|---|
| Leadership |
Senior Vice President
(Frank A Damelio, 2009)
Chairman & CEO
(Jeffrey B. Kindler, 2009, 2006-12-18, 2010-12-06)
Senior Vice President
(William R. Ringo, 2009)
|
|
| Industry | ||
| Retained Earnings |
49142000000.0
(2008-12-31, US$)
|
|
Organization |
||
| Place founded | ||
| Organizations acquired |
2009-10
(Wyeth)
|
|
| Board members |
|
|
| Headquarters |
235 E 42ND ST
(New York City, 10,017, New York)
235 EAST 42 ST
(New York City, 10,017, New York)
|
|
| Child |
Pfizer Asia Contract Operations Pte. Ltd
(2008, 2009)
Pharmacia Australia Pty Ltd
(2004, 2005, 2006, 2007, 2008, 2009)
|
|
| Parent |
2003, 2004, 2005, 2006, 2007, 2008, 2009
|
|
| Phone number |
United States of America
(1-800-879-3477, Customer service)
|
|
Issuer |
||
| Issue | ||
Business Operation |
||
| Net profit | ||
| Total Assets |
111,148,000,000
(2008-12-31, US$)
|
|
| Total Liabilities |
53592000000.0
(2008-12-31, US$)
|
|
| Competitive space |
|
|
| Current Assets |
43076000000.0
(2008-12-31, US$)
|
|
| Current Liabilities |
27009000000.0
(2008-12-31, US$)
|
|
| Cash |
2,122,000,000
(2008-12-31, US$)
|
|
| Operating Income |
23731700000.0
(2006-12-31, US$)
|
|
Customer |
||
| Supplier | ||
Consumer company |
||
| Brands | ||
| Products | ||
Drug manufacturer |
||
| Drugs manufactured |
Inlyta 5 film coated tablet
(United States of America, no, 2012-01-27, 2020-06-30, 2012-01-26, Red, Triangle, 8, 1, Pfizer;5;XNB, dailymed.nlm.nih.gov, NDA202324, no, 0069-0151)
Paclitaxel 100 injection
(United States of America, no, 2011-09-30, 2011-12-07, Yellow, dailymed.nlm.nih.gov, ANDA091540, yes, 0069-0076)
Cladribine 1 injection
(United States of America, no, 2011-07-10, Cladribine 1 injection, 2012-01-11, White, dailymed.nlm.nih.gov, ANDA200510, yes, 0069-0086)
|
|
Ranked item |
||
| Appears in ranked lists |
|
|
Non-profit organization |
||
| Revenue | ||
Employer |
||
| Number of employees |
85,000
|
|
| Employees and other personnel |
|
|
Sponsor |
||
| Sponsorship | ||
Science or Technology Company |
||
| Medical focus | ||
| Products | ||
| Technology Focus | ||
BV: Venture Investor |
||
| Investment Round |
Series D
(19,200,000, Arboretum Ventures, Ardesta, Dow Ventures, EDF Ventures, Lurie Ventures, 2008-08-04, HandyLab Inc.)
|
|
Literature Subject |
||
| Works Written About This Topic | ||
